Department of Labor Seal photos representing the workforce - digital imagery© copyright 2001 photodisc, inc.
Department of Labor Seal www.osha.gov  [skip navigational links] Search    Advanced Search | A-Z Index
<< Chemical Sampling Information (CSI) Link to Printing InstructionsPrinting Instructions
Chemical Sampling Information (CSI) Chemical Sampling Information
Halothane

Quick Links
Search
  
[use word(s)/phrase]
Table of Contents
By Name
A B C D E F G H I J K L M N
O P Q R S T U V W X Y Z


By CAS Number
General Description
    Synonyms: 1-Bromo-1-chloro-2,2,2-trifluoroethane; 2-Bromo-2-chloro-1,1,1-trifluoroethane; Fluothane; 1,1,1-Trifluoro-2-bromo-2-chloroethane; 2,2,2-Trifluoro-1-bromo-1-chloroethane

    OSHA IMIS Code Number: 0395

    Chemical Abstracts Service (CAS) Registry Number: 151-67-7

    NIOSH, Registry of Toxic Effects (RTECS) Identification Number: KH6550000

    NIOSH Pocket Guide to Chemical Hazards, Halothane: chemical description, physical properties, potentially hazardous incompatibilities, and more
Exposure Limits
    American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value (TLV): 50 ppm, 404 mg/m3 TWA; Appendix A4 - Not Classifiable as a Human Carcinogen

    National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Limit (REL): 2 ppm, 16.2 mg/m3 Ceiling (60 Minutes) [Note: REL for exposure to waste anesthetic gas.]
Health Factors
    International Agency for Research on Cancer (IARC) carcinogenic classification: Group 3, not classifiable as to its carcinogenicity to humans [1 MB, PDF]

    Potential symptoms: Irritation of eyes, skin, respiratory system; confusion, drowsiness, dizziness, nausea, analgesia, anesthesia, cardiac arrhythmias; liver, kidney damage; decreased audio-visual performance; in animals: reproductive effects.

    Health Effects: Liver injury (HE3); Narcosis (HE8)

    Affected organs: Eyes, skin, respiratory system, cardiovascular system, CNS, liver, kidneys, reproductive system

    Notes:
    1. OSHA does not have a PEL for halothane.
    2. During halothane metabolism, liver proteins can become trifluoroacetylated to form haptens that trigger the production of IgG antibodies.
    3. Antibodies to liver proteins, including cytochrome P450 2E1 (which metabolizes halothane), have been found in serum from patients with halothane-induced hepatitis, as well as in serum from anesthesiologists occupationally exposed to halothane.
    4. A close correlation between the TWA concentration of halothane in the breathing zone of operating room personnel and the halothane in urine collected after 4 hours of exposure was reported, such that halothane concentrations of 3.9, 6.5, and 92 µg/liter of urine were estimated to correspond with TWA halothane exposures of 0.5, 2.0, and 50 ppm, respectively.

    Date Last Revised: 04/18/2007

    Literature Basis:
    • NIOSH Pocket Guide to Chemical Hazards: Halothane.
    • International Chemical Safety Cards (WHO/IPCS/ILO): Halothane.
    • Imbriani, M., Ghittori, S., Zadra, P. and Imberti, R.: Biological monitoring of the occupational exposure to halothane (fluothane) in operating room personnel. Am. J. Ind. Med. 20(1): 103-112, 1991.
    • Kenna, J.G., Satoh, H., Christ, D.D. and Pohl, L.R.: Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J. Pharmacol. Exp. Ther. 245(3): 1103-1109, 1988.
    • Njoku, D.B., et al.: Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists. Anesth. Analg. 94(2): 243-249, 2002.
    • Pohanish, R.P. (editor): Halothane. In, Sittig’s Handbook of Toxic and Hazardous Chemicals and Carcinogens, Fourth Ed., Vol. 1. Norwich, NY: Noyes Publications, William Andrew Publishing, 2002, pp. 1221-1223.
    • Sutherland, D.E. and Smith, W.A.: Chemical hepatitis associated with occupational exposure to halothane in a research laboratory. Vet. Hum. Toxicol. 34(5): 423-424, 1992.
Monitoring Methods used by OSHA
    Laboratory Sampling/Analytical Method:

    • sampling media: Anasorb 747 Tube (140/70 mg sections)
      analytical solvent: Carbon Disulfide
      maximum volume: 12 Liters   maximum flow rate: 0.05 L/min
      current analytical method: Gas Chromatography; GC/FID
      method reference: OSHA Analytical Method (OSHA 103)
      method classification: Fully Validated

    • sampling media: Anasorb CMS Tube (150/75 mg sections)
      analytical solvent: Carbon Disulfide
      maximum volume: 12 Liters   maximum flow rate: 0.05 L/min
      current analytical method: Gas Chromatography; GC/FID
      method reference: OSHA Analytical Method (OSHA 103)
      method classification: Fully Validated

    • sampling media: Two Charcoal Tubes in series (100/50 mg sections, 20/40 mesh)
      analytical solvent: Carbon Disulfide
      maximum volume: 10 Liters   maximum flow rate: 0.1 L/min
      current analytical method: Gas Chromatography; GC/FID
      method reference: OSHA Analytical Method (OSHA 29)
      method classification: Fully Validated

All Trademarks are the property of their respective owners.

 
Back to TopBack to Top www.osha.gov www.dol.gov

Contact Us | Freedom of Information Act | Customer Survey
Privacy and Security Statement | Disclaimers
Occupational Safety & Health Administration
200 Constitution Avenue, NW
Washington, DC 20210
Page last updated: 03/07/2008